Clinical Trial Update: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating combination chemotherapy with or without PSC 833 and/or interleukin-2, with or without peripheral stem cell transplantation, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)
• PSC 833 (valspodar)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 3 | Status: COMPLETED